Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Invitation to Annual General Meeting 2017

Shareholders in Holmen Aktiebolag (publ) (corp. reg. no. 556001-3301) are hereby invited to attend the Annual General Meeting at 15.00 CET on Monday 27 March 2017 in Vinterträdgården, Grand Hôtel (Royal entrance), Stallgatan 6, Stockholm, Sweden.Registration etc.  Shareholders wishing to participate in the Meeting shall: be entered in the register of shareholders maintained by Euroclear Sweden AB on Tuesday 21 March 2017; give notice of participation by Tuesday 21 March 2017 at the latest, preferably before 17.00 CET, to Holmen AB, Group Legal Affairs, Box 5407, SE-114 84 Stockholm,

Medisch Centrum Voor Dieren (MCD) in Amsterdam joins AniCura

AniCura, one of Europe’s leading providers of high-quality veterinary care for companion animals, acquires the majority of Medisch Centrum Voor Dieren (MCD) in Amsterdam. The cooperation provides MCD with a strong and experienced partner to support the continued development of its veterinary expertise and veterinary offering.The Medisch Centrum Voor Dieren, MCD, was founded in Amsterdam in 2010 by nine veterinary specialists and the clinic manager of the emergency clinic. MCD is one of the most renowned and specialized small animal referral clinics in the Netherlands. It comprises a

Södra's operating profit SEK 452 million for the third four-month period

Södra’s operating profit for the third four-month period amounted to SEK 452 million (502). The full-year profit is in line with expectations and the board proposes a distribution of profit totalling SEK 602 million.“2016 was a year of transition for Södra, with major changes due to robust investment and restructuring but also lower prices for our finished goods. Against this background, operating profit of SEK 452 million for the third four-month period is a show of strength, while full-year profit of SEK 1,005 million is completely in line with expectations”, says Lars Idermark, President

Meir Roimy, Nordic Leisure Group new Chief Financial Officer

Meir Roimy has been appointed as the new CFO of Nordic Leisure Group, with responsibility for the group's accounting, finance, legal and HR departments. Meir will be part of Group senior Management. Meir, a Certified Public Accountant who holds a B.A. in accounting and economics, has a 10 year experience in the IT and iGaming industries, mostly from Superbet and Playtech. "It is with great joy that I welcome Meir Roimy to become the Group CFO. Meir has a solid knowledge of the industry, and I am confident that with his expertise he will streamline the responsibilities, and also

Revenio Group Corporation: Notice pursuant to Chapter 9, Section 10 of the Securities Market Act

Revenio Group Corporation, Stock Exchange Release, February 17, 2017 at 10:00 NOTICE PURSUANT TO CHAPTER 9, SECTION 10 OF THE SECURITIES MARKET ACT Revenio Group Corporation has today received a notification of change in holdings in accordance with Chapter 9, Section 5 of the Securities Markets Act that Mr. Jyri Merivirta's share of the total number of shares and voting rights in Revenio Group Corporation has decreased to less than one fifth (1/5). Mr. Jyri Merivirta now holds 250.00 shares in Revenio Group Corporation, which is 3.13 per cent of the company's shares and voting

Outokumpu Prodec high machinability bar to be supplied by IMS in the Benelux

Outokumpu OyjPress releaseFebruary 17, 2017 at 10.00 am EET  Outokumpu, IMS Nederland and IMS Belgium announced today an agreement where IMS will act as exclusive distributor of Outokumpu Prodec high machinability round bars in the Benelux. IMS is a leading special and stainless steel bar distributor located in the Netherlands and Belgium. Says John Stansfield, head of sales for Outokumpu Long Products Europe: “We’re very pleased to announce this agreement with IMS. With Prodec IMS customers have access to industry’s leading machinability stainless bar. We look forward working

Invitation to Presentation of SimCorp’s Annual Report 2016

SimCorp will publish its Annual Report 2016 to NASDAQ OMX Copenhagen A/S Friday, February 24, 2017 at around 8:00 AM (CET). SimCorp’s Executive Management Board will present the report at a conference call the same day at 11:00 AM (CET). Please use any of the following phone numbers to dial in to the conference call: From Denmark:                 +45 3848 7513From USA:                        +1 212 444 0412From other countries:        +44 (0) 20 3427 1905 The pin code to access the call is 1470699. At the end of the presentation there will be a Q&A session. It will also

Caverion Corporation's Annual Report 2016 published

Caverion Corporation Stock exchange release February 17, 2017 at 9.55 a.m.Caverion Corporation's Annual Report 2016 published Caverion Corporation’s Annual Report 2016 has been published in English and Finnish at: annualreport2016.caverion.com (in English)vuosikertomus2016.caverion.com (in Finnish)The online report provides information on Caverion’s strategy, business operations, operating environment and sustainability. The Financial Statements for the financial year 2016, including the Board of Directors' report and the Auditors' report are published as a separate pdf

SUMMARY OF YEAR-END REPORT 2016

The selective mining strategy has contributed to improved EBITDA and a reduced Cash Cost below the prevailing gold priceThe full report, in Swedish only, is available on the Company´s website, www.endomines.com Highlights Q4/2016 (vs Q4/2015) · Head grade was 3.1 g/t (1.7) · EBITDA was 1.5 MSEK (-14.5) · Gold production was 109.8 kg (118.5), -7 % · Revenues were 37.5 MSEK (28.3), +33% · Cash cost was 1,060 USD/oz (1,202) · Assets were written down by 56.5 MSEK (31.6) · Profit after tax was -84.5 MSEK (-85.5) · Earnings per share amounted to -8.05 SEK (-13.52)

Promising results in toxicological pilot studies with SpagoPix

Collective data from recently completed toxicity studies show that the product candidate SN132D can be given safely at doses that widely exceeds the expected clinical dose.At the end of 2016, Spago Nanomedical formally announced its product candidate in the SpagoPix project. The product candidate, designated SN132D, has now been investigated in several preclinical pilot studies in order to reduce risk and prepare for the regulatory safety program prior to clinical studies. The pilot studies has been performed as a series of in vivo experiments where acute- and sub-acute toxicology has

Seqr partners with Facestore launching in 25,000 online stores

Seqr, the innovative and easy mobile payment solution developed by Seamless, has partnered with Facestore to launch a new official payment method for consumers on the giant social commerce platform. Facestore will launch Seqr as a secure online payment method to its 25,000 online stores in Portugal. This partnership will provide merchants using the Facestore distribution platform to offer the Swedish payment option to its customers - not only does Seqr provide merchants with the lowest transaction costs in the market, compared to credit card services, but also benefits consumers with a

Year-end report October - December 2016

Fourth quarter · Net sales amounted to SEK 32,0 (24,9) million · EBITDA amounted to SEK 0,9 (-6,7) million · Operating profit amounted to SEK -4,2 (-12,1) million · Profit before tax amounted to SEK -6,3 (-14,6) million · Earnings per share before dilution amounted to SEK -0,15 (-0,90) · New cooperation agreement signed with partners for expansion into the US and Canada Full year · Net sales amounted to SEK 101,9 (58,1) million · EBITDA amounted to SEK -9,5 (-22,0) million · Operating profit amounted to SEK -30,0 (-37,7) million · Profit before tax

MEDIVIR AB – FINANCIAL STATEMENT, JANUARY – DECEMBER 2016

Significant events during the fourth quarter · Medivir focuses research and development operations exclusively on oncology and reorganises in order to achieve significant cost savings. As a result of the operative transformation a non-recurring sum of SEK 49.1 million was charged to the profit/loss for the period and of SEK 52.6 million for the full year. · Medivir divests its pharmaceutical company, BioPhausia (Nordic Brands), to Karo Pharma for SEK 908 million and reports a consolidated capital gain of SEK 534.8 million, thereby applying IFRS 5 (see p. 12). · Medivir

Dome Energy resumes drilling program in Orangefield, Texas

Dome Energy AB.  (herein after “Dome” and/or “the Company”) today announces that they resumes the drilling program in Orangefield, Texas. ·  Program in Orangefield with a planned drilling start in March for the two first wells ·  Hager # 39 and # 40 are planned to be drilled to a depth of 5,000 ft ·  Estimated investment $550,000 per well ·  The first two of more than 20 possible wells to be drilled in Orangefield Paul Morch, CEO: “It is with the great pleasure to announce that we are resuming our drilling program in Orange Field, which initially

Healthcare start up Nightingale invited to solve world’s biggest health problem with the UN and MIT

Nightingale Health’s blood analysis technology has been chosen from hundreds of applications to be presented at the Solve pitch event at United Nations headquarters in March. Solve is a program led by MIT seeking solutions for the world's most challenging problems: refugee education, carbon emissions and in this case, chronic diseases. Nightingale Health is a pioneering healthcare company. Their unique solution was chosen as one of 15 finalists in the chronic diseases challenge. Nightingale’s revolutionary technology provides detailed biological data from a single blood sample. This

Pioneering Healthcare Company changes name from Brainshake to “Nightingale Health”

After three years of fast growing business in the medical research market, the company known as Brainshake has unveiled its new company name, Nightingale Health. This coincides directly with the company’s move in 2017 to clinical testing in Europe. With its unique, proprietary and powerful blood testing re-invention, Nightingale aims to solve the world’s biggest health problem. The technology has been proven to advance research in chronic diseases such as heart disease and diabetes, and is supported by over 100 peer-reviewed biomedical publications. When asked about the new name, CEO Teemu

Resurs Bank issues SEK 300 million of senior unsecured bonds

Resurs Bank AB (publ), a wholly owned subsidiary of Resurs Holding AB (Nasdaq Stockholm: RESURS), has issued SEK 300 million of senior unsecured bonds in the Nordic market. The bonds have a maturity of 3 years and will be listed at Nasdaq Stockholm. The 3-year bonds are issued under Resurs Bank's MTN programme (total frame of SEK 3 billion) with a coupon of 3m Stibor +1.55%. Trade date is 16 February 2017. Nordea Bank AB has been used as bookrunner. Transaction details: Issuer: Resurs Bank AB (publ)  Instrument: Senior unsecured bonds  Maturity: 24 February 2020   Coupon: 3

Resurs Bank issues SEK 300 million of senior unsecured bonds

Resurs Bank AB (publ), a wholly owned subsidiary of Resurs Holding AB (Nasdaq Stockholm: RESURS) has issued SEK 300 million of senior unsecured bonds in the Nordic market. The bonds have a maturity of 3 years and will be listed on Nasdaq Stockholm. The 3-year bonds are issued under Resurs Bank's MTN programme (total frame of SEK 3 billion) with a coupon of 3m Stibor +1.55%. Trade date 16 February 2017 and Nordea Bank AB has been used as bookrunner. Transaction details: Issuer: Resurs Bank AB (publ)  Instrument: Senior unsecured bonds  Maturity: 24 February 2020   Coupon: 3

Full Year Report January – December 2016

· Sales increased by 6 percent to 3,957 MSEK (3,719) for the fourth quarter and by 7 percent to 15,551 MSEK (14,486) for the full year. In local currencies, sales increased by 3 percent for the fourth quarter and by 7 percent for the full year. · Operating profit from product areas1) increased by 5 percent to 954 MSEK (908) for the fourth quarter and by 8 percent to 3,990 MSEK (3,690) for the full year. In local currencies, operating profit from product areas1) was flat for the fourth quarter and increased by 8 percent for the full year. · Operating profit2) amounted to 954 MSEK (908)

Strong finish to a new record year

“When we set new targets for Ework’s onward growth journey at the beginning of last year, we aimed high. We can now look back on a 2016 when we beat our targets, with continued high sales growth and increasing earnings per share. We also continued to invest in our future.” Extract from CEO Zoran Covic’s commentary to the Year-end Report.Fourth quarter 2016 compared to the corresponding period 2015 · Net sales increased by 33% to SEK 2,320 M (1,741). · Operating profit up by 33% to SEK 29.3 M (22.0). · Order intake amounted to SEK 3,917 M (2,949), in the fourth quarter, a 33%

Arise announces a fully supported rights issue of convertible bonds to proactively develop its position and strengthen its financial flexibility.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, CANADA, JAPAN, HONG KONG, SINGAPORE, SOUTH AFRICA, NEW ZEALAND, AUSTRALIA OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION OR DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE.Pursuant to the authorisation of the General Meeting held on 3 May 2016, the Board of Directors of Arise AB (publ) (“Arise” or “the Company”) decided on 17 February 2017 that the Company is to raise a convertible loan of a nominal maximum of approximately MSEK 245 with

D. Carnegie & Co invites to an audiocast in connection with publication of the year-end report 2016

D. Carnegie & Co AB (publ) – listed on Nasdaq Stockholm – invites to an audiocast at 10.00 am on February 24, in connection with the publication of its year-end report 2016, which will be published that day at 7.00 am.Shareholders, analysts and other interested parties are welcome to participate in an audiocast in which the financial report for the fourth quarter will be presented by CEO Ulf Nilsson and CFO Per-Axel Sundström. The presentation and related material will be accessible through www.dcarnegie.se and can be followed via web or by telephone on the numbers provided below. Kindly

Interim Report January 1 – December 31, 2016

All-time high Sales for a quarter and the first shipment of our new product Nevisense ViewThe fourth quarter in figures · Net sales amounted to TSEK 1,935 (1,181). · The loss after tax amounted to TSEK 14,623 (11,154). · The loss per share amounted to SEK 1.77 (1.35). · The cash flow from current operations was negative in the amount of TSEK 13,032 (13,864). · Significant margin improvement with gross margin increasing to 35.0% in Q4 (18.4%). The full year in figures · Net sales amounted to TSEK 6,436 (4,151). · The loss after tax amounted to TSEK 53,086 (41,532).

There are no items matching the current filter
There are no more items matching the current filter
Back to top